Tissue engineering and cell and gene therapies are in a state of constant development and pave the way for personalized medicine. Promising results from different fields reflect the paradigm change in healthcare toward tailor-made medication. A wide range of cellular products (known as ATMPs) are being developed with a view to curing life-threatening diseases, increasing quality of life, and preventing the serious side effects of conventional therapies.
- Ocular diseases
We offer you customized cell and gene therapy logistics:
As a Lufthansa Cargo subsidiary, we control the entire supply chain and are not limited by airport boundaries. Our own expectation of excellence ensures a 99.5% performance level on a global scale. We have a zero tolerance policy for errors in the field of hematopoietic stem cells.
In addition, you can expect: